Association Between Circulating Proprotein Convertase Subtilisin/Kexin Type 9 and Major Adverse Cardiovascular Events, Stroke, and All-Cause Mortality: Systemic Review and Meta-Analysis

Association Between Circulating Proprotein Convertase Subtilisin/Kexin Type 9 and Major Adverse Cardiovascular Events, Stroke, and All-Cause Mortality: Systemic Review and Meta-Analysis

Background: Proprotein convertase subtilisin/kexin type 9 (PCSK9), a pivotal protein in low-density lipoprotein cholesterol metabolism, has been validated to be an established target for cardiovascular (CV) risk reduction. Nevertheless, prospective studies concerning the associations between circula...

Full description

Bibliographic Details
Main Authors: Yimo Zhou, Weiqi Chen, Meng Lu, Yongjun Wang
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
proprotein convertase subtilisin/kexin type 9
cardiovascular events
stroke
mortality
association
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2021.617249/full

Internet

https://www.frontiersin.org/articles/10.3389/fcvm.2021.617249/full

Similar Items